The tariff classification of Ozanimod Hydrochloride (CAS No. 1618636-37-5), Brivaracetam (CAS No. 357336-20-0) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk form, from Taiwan
Reasoning
The tariff classification of Ozanimod Hydrochloride (CAS No. 1618636-37-5), Brivaracetam (CAS No. 357336-20-0) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk form, from Taiwan
Cite this ruling
CBP Ruling N316489 (2933595900): The tariff classification of Ozanimod Hydrochloride (CAS No. 1618636-37-5), Brivaracetam (CAS No. 357336-20-0) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk form, from Taiwan
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 293359
The tariff classification of Zinc orotate (CAS-60388-02-5); Tribenzylamine (CAS-620-40-6); and 1-Phenethyl-4-piperidone (CAS-39742-60-4), all in bulkform, from Germany and France
The tariff classification of p-chloro phenyl piperazine HCL (CAS# 103078-12-1) from France.
The tariff classification of d,l-Desoxyephedrine (CAS 4846-07-5), in bulk
The tariff classification of five drugs: Ciprofloxacin Hydrochloride (CAS
The tariff classification of five drugs: Ciprofloxacin Hydrochloride (CAS